Soros Fund Management LLC Decreases Holdings in The Allstate Co. (NYSE:ALL)

Soros Fund Management LLC lowered its stake in shares of The Allstate Co. (NYSE:ALL - Free Report) by 11.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 80,970 shares of the insurance provider's stock after selling 10,500 shares during the period. Soros Fund Management LLC's holdings in Allstate were worth $15,356,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in ALL. FSA Wealth Management LLC purchased a new stake in shares of Allstate in the third quarter worth approximately $26,000. Northwest Investment Counselors LLC purchased a new stake in Allstate in the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC bought a new position in Allstate during the 3rd quarter valued at $29,000. Family Firm Inc. purchased a new position in Allstate during the 2nd quarter worth $38,000. Finally, Transamerica Financial Advisors Inc. bought a new stake in shares of Allstate in the 3rd quarter worth $58,000. Institutional investors and hedge funds own 76.47% of the company's stock.

Insiders Place Their Bets

In related news, insider John E. Dugenske sold 36,367 shares of the company's stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.80% of the company's stock.

Allstate Stock Performance

Shares of NYSE:ALL traded down $2.32 during trading on Friday, hitting $201.91. 274,875 shares of the company were exchanged, compared to its average volume of 1,544,082. The Allstate Co. has a 52-week low of $134.17 and a 52-week high of $209.88. The stock has a 50 day moving average of $194.09 and a 200 day moving average of $180.03. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The company has a market cap of $53.47 billion, a PE ratio of 13.23, a P/E/G ratio of 1.79 and a beta of 0.50.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company had revenue of $16.63 billion during the quarter, compared to analysts' expectations of $14.57 billion. Allstate's revenue for the quarter was up 14.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.81 earnings per share. As a group, equities research analysts predict that The Allstate Co. will post 16.26 EPS for the current year.

Allstate Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 1.82%. The ex-dividend date of this dividend is Friday, November 29th. Allstate's payout ratio is 23.83%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on ALL. Piper Sandler boosted their price target on shares of Allstate from $206.00 to $244.00 and gave the stock an "overweight" rating in a report on Tuesday, November 26th. The Goldman Sachs Group boosted their target price on Allstate from $209.00 to $230.00 and gave the stock a "buy" rating in a research note on Friday, November 15th. Morgan Stanley increased their price target on Allstate from $220.00 to $228.00 and gave the company an "overweight" rating in a research report on Thursday, November 7th. Roth Mkm restated a "buy" rating and issued a $200.00 price objective on shares of Allstate in a research note on Wednesday, August 14th. Finally, JPMorgan Chase & Co. raised their target price on Allstate from $205.00 to $207.00 and gave the company an "overweight" rating in a research report on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $217.19.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.